Literature DB >> 2867576

The effects of naloxone on opiate and placebo analgesia in healthy volunteers.

J Posner, C A Burke.   

Abstract

Two double blind cross-over studies were performed using a submaximal effort tourniquet test (SETT) in healthy volunteers to investigate the role of endogenous opioids in placebo analgesia. In the first study IV naloxone significantly inhibited analgesia, miosis and sedation produced by the opioid dipipanone 10 mg in 12 subjects. In the second naloxone, which did not produce hyperalgesia, failed to inhibit significant placebo analgesia in 12 subjects. The results do not support the involvement of endogenous opioids in ischemic limb pain or placebo analgesia under these conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867576     DOI: 10.1007/bf00432515

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Placebo and naloxone can alter post-surgical pain by separate mechanisms.

Authors:  R H Gracely; R Dubner; P J Wolskee; W R Deeter
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

2.  Placebo analgesia, endorphins, and naloxone.

Authors:  A Goldstein; P Grevert
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

3.  Mechanism of placebo analgesia.

Authors:  A D Korczyn
Journal:  Lancet       Date:  1978-12-16       Impact factor: 79.321

4.  Effects of naloxone on post-operative pain and steroid-induced analgesia.

Authors:  P Skjelbred; P Løkken
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

5.  Mechanism of morphine-induced miosis in the dog.

Authors:  H K Lee; S C Wang
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

6.  Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects.

Authors:  P Grevert; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

7.  Antitussive effect of the optical isomers of mu, kappa and sigma opiate agonists/antagonists in the cat.

Authors:  T T Chau; F E Carter; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

8.  The mechanism of placebo analgesia.

Authors:  J D Levine; N C Gordon; H L Fields
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

9.  Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials.

Authors:  M S Buchsbaum; G C Davis; D Naber; D Pickar
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes.

Authors:  J C Willer; H Dehen; J Cambier
Journal:  Science       Date:  1981-05-08       Impact factor: 47.728

View more
  11 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

Review 2.  Implications of placebo theory for clinical research and practice in pain management.

Authors:  C Peck; G Coleman
Journal:  Theor Med       Date:  1991-09

3.  Introduction to placebo effects in medicine: mechanisms and clinical implications.

Authors:  Karin Meissner; Niko Kohls; Luana Colloca
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

4.  Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response.

Authors:  J J Lipman; B E Miller; K S Mays; M N Miller; W C North; W L Byrne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Nociceptive flexion reflex and pain rating responses during endogenous opiate blockade with naltrexone in healthy young adults.

Authors:  Christopher R France; Mustafa al'Absi; Christopher Ring; Janis L France; Angie Harju; Lorentz E Wittmers
Journal:  Biol Psychol       Date:  2006-12-27       Impact factor: 3.251

6.  The effect of opioid receptor blockade on the neural processing of thermal stimuli.

Authors:  Eszter D Schoell; Ulrike Bingel; Falk Eippert; Juliana Yacubian; Kerrin Christiansen; Hilke Andresen; Arne May; Christian Buechel
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

Review 7.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.

Authors:  Randy Torralva; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

Review 8.  Endogenous opioid antagonism in physiological experimental pain models: a systematic review.

Authors:  Mads U Werner; Manuel P Pereira; Lars Peter H Andersen; Jørgen B Dahl
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 9.  Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities.

Authors:  Vanessa Brown; Marta Peciña
Journal:  Front Psychiatry       Date:  2019-09-24       Impact factor: 4.157

10.  Placebo analgesia effects across central nervous system diseases: what do we know and where do we need to go?

Authors:  Susan Tomczak Matthiesen; Sigrid Juhl Lunde; Sophie Wohlert Kjær; Elisa Carlino; Lene Vase
Journal:  Pain Rep       Date:  2019-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.